MDMA Statement on Supreme Court Decision on the “Affordable Care Act”
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the U.S. Supreme Court’s decision on the “Affordable Care Act” (ACA):
“Today’s decision adds new urgency to repealing the medical device tax so that patients and providers can continue to expect innovative devices and technologies. While MDMA and our members still have seen no evidence or reports showing any ‘windfall’ for medical device companies as a result of the ACA, it is clear that this misguided policy has already led to job losses and cuts to research and development.
“If the true goal of health care reform is to reduce costs and to improve patient care, then Congress and the President need to repeal the device tax so America’s medical technology innovators can continue to develop cutting edge products. Doing so will be a win-win for patients and jobs.”